Related Experiment Video
Updated: Jul 18, 2026

12:23
Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
Immunogenetics of pemphigus: an update.
François Tron1, Danièle Gilbert, Pascal Joly
1Faculté de Médicine et de Pharmacie, INSERM U519, Université de Rouen, Rouen, France.
Autoimmunity
|November 15, 2006
Summary
Pemphigus, a group of autoimmune blistering diseases, likely has a genetic basis involving multiple genes. Research is advancing to uncover these genetic factors using new molecular tools and studying candidate genes.
Area of Science:
- Immunology
- Genetics
- Dermatology
Background:
- Pemphigus are rare organ-specific autoimmune diseases.
- Their development involves environmental, genetic, and stochastic factors.
- A genetic basis for pemphigus, similar to other autoimmune diseases, is strongly suggested, likely involving multiple genes.
Purpose of the Study:
- To explore the genetic underpinnings of pemphigus.
- To review current strategies for identifying pemphigus-associated genetic loci.
- To highlight recent advancements in understanding the genetic basis of these autoimmune blistering diseases.
Main Methods:
- Review of conventional case-control association studies.
- Analysis of candidate genes.
- Examination of the major histocompatibility complex (MHC) class II locus.
- Incorporation of recent molecular tools and physiopathological insights.
Main Results:
- The major histocompatibility complex, particularly the class II locus, shows a highly replicable association with pemphigus.
- Candidate gene studies reveal associations at various levels of the autoimmune process.
Conclusions:
- Pemphigus has a significant genetic component.
- Advances in molecular biology and understanding of disease pathophysiology are crucial for identifying pemphigus genetic loci.
- Further research into candidate genes is essential for a comprehensive understanding of pemphigus etiology.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
